Related Experiment Video
Updated: Jun 4, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Management of dyslipidaemia in patients with comorbidities-facing the challenge
Lisa Frühwald1,2, Peter Fasching1,2, Dobromir Dobrev3,4,5
15th Medical Department with Endocrinology, Rheumatology and Acute-Geriatrics, Vienna Health Association, Ottakring Clinic, Montleartstraße 37, 1160 Vienna, Austria.
Insights
This review explores the benefits and risks of lipid-lowering drugs for patients with liver disease. It highlights the need for more research to guide treatment for those with both liver and cardiovascular conditions.
Area of Science:
- Cardiology
- Hepatology
- Pharmacology
Background:
- Elevated liver enzymes often lead to discontinuation of lipid-lowering drugs.
- This can prevent patients from receiving cardiovascular benefits.
- There is limited real-world evidence on these drugs in patients with liver disease.
Purpose of the Study:
- To review the evidence on benefits and risks of lipid-lowering drugs in patients with liver disease.
- To focus on potential liver-related side effects of these medications.
- To provide guidance for treating patients with liver dysfunction.
Main Methods:
- Literature search of PubMed.
- Examination of efficacy and safety profiles of various lipid-lowering agents.
- Focus on statins, ezetimibe, bempedoic acid, PCSK9 inhibitors, fibrates, and icosapent ethyl.
Main Results:
- Assessing drug-induced hepatotoxicity is challenging due to reliance on case reports.
- Robust evidence for lipid-lowering therapy in pre-existing liver disease is lacking.
- Available data on lipid-lowering drugs and liver health were summarized.
Conclusions:
- Further research is needed to optimize treatment strategies.
- Patients with coexisting liver and cardiovascular disease require tailored approaches.
- Balancing cardiovascular protection and liver safety is crucial.
Abstract:
This review aims to examine the evidence on the benefits and risks of lipid-lowering drugs in patients with liver disease. Elevated liver enzyme levels often lead to cautious discontinuation of these drugs, potentially withholding from patients their benefit in reducing cardiovascular disease morbidity and mortality. Using a literature search of PubMed, we examine the efficacy and safety profiles of various lipid-lowering agents, including statins, ezetimibe, bempedoic acid, PCSK9 inhibitors, fibrates, and icosapent ethyl, focusing particularly on their potential side effects related to liver health. A major challenge in the assessment of drug-induced hepatotoxicity is the fact that it relies heavily on case reports rather than real-world evidence. There is currently a lack of robust evidence on lipid-lowering therapy in people with pre-existing liver disease. Nevertheless, we have attempted to summarize the available data for all the drugs mentioned in order to provide guidance for the treatment of patients with liver dysfunction. This review highlights the need for further research to optimize treatment strategies for patients with coexisting liver and cardiovascular disease.
More Related Videos
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...